nmin’s strategic initiative (si) program focuses on supporting just-in-time research development, commercialization and knowledge mobilization/transfer opportunities that arise in-year and/or require a rapid response in order to generate, promote or accelerate the economic and social benefits of previous or new nmin or related research investments. these funds are intended to provide support for research, post-discovery commercialization, business planning and knowledge dissemination, mobilization, or translation activities. the projects must be scaled to be achievable within a one-year/12-month timeframe and be aligned with nmin’s mission and vision. ideally, the si will be undertaken in partnership with nmin partners, stakeholders, and/or end-user organizations.

nmin’s strategic initiative (si) program focuses on supporting just-in-time research development, commercialization and knowledge mobilization/transfer opportunities that arise in-year and/or require a rapid response in order to generate, promote or accelerate the economic and social benefits of previous or new nmin or related research investments. these funds are intended to provide support for research, post-discovery commercialization, business planning and knowledge dissemination, mobilization, or translation activities. the projects must be scaled to be achievable within a one-year/12-month timeframe and be aligned with nmin’s mission and vision. ideally, the si will be undertaken in partnership with nmin partners, stakeholders, and/or end-user organizations.

nmin will consider support for proposed projects that can be completed within a period of one year, and that include, but are not limited to, at least one of the following objectives:

1. facilitation of projects that provide strategic added value to nmin-funded research and development initiatives, as well as nanomedicine-related contributions to non-nmin funded initiatives. preference will be given to projects that are related or add value to existing nmin funded projects. (refer to nmin’s project database.)

2. development of a business plan towards facilitating a commercial legacy for nmin research investments/teams.

3. contribution to the translation, mobilization and/or application of nmin-funded research findings to accelerate canadian innovation, productivity and economic competitiveness and/or improve the quality of life for canadians.

4. development of policy frameworks, national strategies, tools, technologies, products, and/or services arising from nmin research and/or aligned with nmin’s vision and mission.

budgets may be requested for a maximum of one year to a maximum value of $50,000.00.

exceptional contribution to science policy award nominate an individual who has made significant contributions to science policy! the second exceptional contribution to science policy award celebrates an individual who has championed and inspired the science policy community in canada. cspc encourages all individuals and/or organizations to nominate a person who meets at least four of the selection criteria described here.  application deadline: august 28th.    nomination form about the award science policy award of excellence youth category   do you have a great idea for an evidence-based policy proposal to share with canada? we want to hear it. join the line-up of brilliant young awardees who have previously received this award and bring national attention to your proposal. we encourage all individuals below 35 years of age from any discipline, any sector, and at any stage of their career, to apply for this award. the deadline is fast approaching. more information on application and selection criteria are linked below.  about the award submit a proposal

cmc microsystems recognizes excellence in canadian micro-nano research by canada’s national design network through its annual douglas r. colton award. established in honour of the founding president of cmc microsystems, this award includes a medal and a monetary prize of $4,500.

faculty, 世界杯2022赛程表淘汰赛 or alumni who have successfully completed a master’s or phd degree in a canadian university within the previous three calendar years are eligible for this award.

call for advanced technology

there have been significant technological advancements in autonomous infrastructure within the transportation and mining industry with heavy duty equipment, trucks, buses, recreational vehicles and others used for goods movement. we are interested in how companies and organizations with technical readiness can assist the forestry industry in advancing their current operations and utilizing existing intelligent transportation systems (its).

background

across ontario, the forestry industry is faced with timber hauling logistics challenges. currently, the hauling capacity cannot match the pace of harvesting equipment and mill consumption. wood is often left roadside longer than it should be in many forest management units, waiting for transportation before being brought to the mills. ultimately, wood left roadside leads to issues at various processing facilities, including lack of inventory in yards and increased costs.

nextfor, in partnership with the nawiinginokiima forest management corporation (nfmc) are interested in identifying parties who can bring innovative, technical solutions to address the identified timber hauling logistics challenges.

goals and outcomes

the purpose of this eoi is to gain an understanding of the available state of technology and organizational capacity to undertake future full-scale field trial(s) and pilot projects to demonstrate innovative technology and solutions to the identified challenge, specifically:

• explore available technologies and providers who can address the logistics issues facing wood transport processes,
• find technology (hardware or software) in the pre-commercial or commercial stage which addresses the unique needs of the forestry sector, and;
• identify and connect a consortium of service providers for future rfp and logistics opportunities.

the fy20 defense appropriations act provides funding to the department of defense combat readiness – medical research program (crrp) to support military-relevant advanced technology and therapeutic research related to forward-deployable solutions that can promptly address life-threatening injuries, medical threats, and treatments for service members in current and future battlefield settings.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated broad agency announcement/funding opportunity is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

the fy20 congressional language for the crrp considered research that would enable the warfighter to better respond to serious injury, as well as solutions to mitigate the long-term effects of battlefield trauma.  the fy20 crrp broad agency announcement and general submission instructions for the following award mechanism are posted on the grants.gov website. 

the fy20 crrp is soliciting research applications addressing at least one of the focus areas described below.  the focus areas broadly describe current needs to ensure readiness for delivering front-line care in combat situations and for delivering medical damage control capability, assets, and lifesaving interventions to address the emerging needs of the warfighter and service medics during prolonged and en route care in austere and combat environments, including the acute and early management of combat-related trauma at the point of injury. 

applications submitted to the fy20 crrp must address at least one of the following focus areas:

• multiple-use scalable wound-care solutions that can address prevention of bleeding and infection, delivery of therapeutics, and promotion of healing spanning acute through chronic care
• repair and/or restoration of combat-related genitourinary organ and tissue damage
• solutions for assessment of mild traumatic brain injury in deployed and far-forward settings to include portable devices
• research and development of freeze-dried plasma and platelets to address hemorrhage and resuscitation
• solutions to enhance warfighter readiness in battlefield and austere environments including the prevention and treatment of:

○        gastrointestinal illness such as enterotoxigenic escherichia coli diarrheal disease and inflammatory bowel disease

○        sleep disorders

○        myalgic encephalomyelitis/chronic fatigue syndrome

○        infectious diseases

• enhanced delivery and utilization of telemedicine platforms

https://cdmrp.army.mil/funding/crrp

rapid development and translational research award – preproposal due september 10, 2020

independent investigators at all academic levels (or equivalent)

proposals/applications must be submitted through an extramural organization

intramural investigators may be named as a collaborator on a proposal/application submitted through an extramural organization

• supports new ideas that represent military-relevant advanced technology and therapeutic research related to forward-deployable solutions that can promptly address life-threatening injuries, medical threats and treatments for warfighters in current and future battlefield setting.
• supports research that will accelerate the movement of promising ideas into clinical applications, including healthcare products, technologies, and/or practice guidelines. this mechanism is not intended to support fundamental basic research.
• primary emphasis will be placed on the potential impact of the proposed work.
• preclinical research supported by substantial preliminary or published data that validates clinical translation is appropriate for this mechanism.
• clinical trials are not allowed.
• must address at least one of the fy20 crrp focus areas.
• maximum funding of $2,000,000 for direct costs (plus indirect costs)
• maximum period of performance is 2 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final broad agency announcement and general submission instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for the award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when the broad agency announcement is released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the crrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org